Skip to content
Sai Life Sciences logo

Sai Life Sciences IPO

MainboardListedPharma & Healthcare
Check allotment status
Issue price
₹549
Listing price
₹650
+18.40%
Current price
₹1,928.8
+251.33%
Subscribed
10.27x
Issue size
₹3,042.62 Cr
Listed on
18 Dec 2024

IPO timeline

  1. Opens
    11 DecWed
  2. Closes
    13 DecFri
  3. Allotment
    16 DecMon
  4. Refunds
    17 DecTue
  5. Demat credit
    17 DecTue
  6. Listing
    18 DecWed

Issue details

Price band
₹522 – ₹549 per share
Issue size
₹3,042.62 Cr
Fresh issue
Not available
Offer for sale
Not available
Issue type
Fresh capital cum OFS
Face value
₹1 per share
Lot size
27 shares
Minimum investment
₹14,823
Listing on
BSE, NSE
Exchange code
SAILIFE · 544306

This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)127₹14,823
Retail (Max)13351₹1,92,699
S-HNI (Min)14378₹2,07,522
B-HNI (Min)681,836₹10,07,964

Reservation

QIB
2,77,10,560 shares (50.00% of the Offer)
NII
83,13,169 shares (15.00% of the Offer)
Retail
1,93,97,394 shares (35.00% of the Offer)

Allotment status

Registrar: KFin Technologies Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on KFin Technologies
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
16 Dec 2024
Refunds initiated
17 Dec 2024
Shares credited to demat
17 Dec 2024
Listing
18 Dec 2024

Grey market premium (GMP)

Updated 17 Dec 2024, 12:00 PM IST
Current GMP
₹70
+13.00%
Estimated listing price
₹619
Issue price ₹549
Highest
₹70
17 Dec
Lowest
₹27
13 Dec

GMP by day (₹ per share)

Day-wise GMP table
DateGMPPremiumEst. listing
17 Dec 2024₹70+13.00%₹619
16 Dec 2024₹42+8.00%₹591
14 Dec 2024₹38+7.00%₹587
13 Dec 2024₹27+5.00%₹576
12 Dec 2024₹38+7.00%₹587
11 Dec 2024₹33+6.00%₹582
10 Dec 2024₹35+6.00%₹584
9 Dec 2024₹30+5.00%₹579
7 Dec 2024₹30+5.00%₹579
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 10 Nov 2026, 06:44 AM IST
Overall subscription
10.27x
Fully subscribed
  • QIB29.78x
  • NII (HNI)4.99x
  • Retail1.39x

Financials

Amounts in Rs. Crore
P/E Ratio
203.82
EPS (₹)
2.69
RoE
11.79%
RoCE
15.96%
RoNW
8.13%
PAT Margin
5.65%
NAV (₹)
53.94

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Period ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets2,476.782,275.142,186.652,164.23
Total Income693.351,494.271,245.11897.74
Profit After Tax28.0182.819.996.23
NET Worth1,044.75974.34887.29877.76
Total Borrowing764.49710.16699.23751.32
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Sai Life Sciences
This IPO
₹3,042.62 Cr203.828.13%5.65%10.27x+18.40%
Anthem Biosciences
Mainboard · listed 21 Jul 2025
₹3,395 Cr70.6220.82%23.38%67.42x+26.85%
Inventurus Knowledge Solutions
Mainboard · listed 19 Dec 2024
₹2,497.92 Cr54.6632%20.38%52.68x+42.96%
Sagility India
Mainboard · listed 12 Nov 2024
₹2,106.4 Cr61.520.29%11.83%3.2x+3.53%
Akums Drugs & Pharmaceuticals
Mainboard · listed 6 Aug 2024
₹1,856.74 Cr13580-0.57%0.02%63.44x+6.77%
Indegene
Mainboard · listed 13 May 2024
₹1,841.76 Cr33.5318.23%12.62%70.3x+44.91%
Symbiotec Pharmalab
Mainboard · listed 1 Sep 2026
₹1,757 Cr56.819.48%12.60%71.26x0.00%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹918.98 Cr total

How Sai Life Sciences plans to use the money raised, as stated in the offer document.

  1. Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company₹720 Cr
  2. General corporate purposes₹198.98 Cr

About Sai Life Sciences

Sai Life Sciences Limited was incorporated on 25 January 1999. It is a pure-play, fully integrated, innovator-focused contract research, development and manufacturing organisation (CRDMO). It provides end-to-end services across drug discovery, development and manufacturing for small molecule new chemical entities, serving global pharmaceutical innovators and biotech firms. It has both discovery and contract research and CMC and CDMO capabilities. Its promoters include Kanumuri Ranga Raju, Krishnam Raju Kanumuri, Kanumuri Mytrey and Sai Quest Syn. The IPO was Rs 3,042.62 crore, with Rs 950.00 crore of fresh issue and Rs 2,092.62 crore of offer for sale, mostly by TPG and HBM investors, with Sai Quest Syn also selling. Fresh money was mainly planned for repaying borrowings.

Strengths

  • Total income rose from Rs 897.74 crore in FY2022 to Rs 1,494.27 crore in FY2024.
  • Profit after tax rose from Rs 9.99 crore in FY2023 to Rs 82.81 crore in FY2024.
  • Rs 950.00 crore of the issue was fresh capital, mostly for repaying debt.
  • It serves global drug innovators across discovery, development and manufacturing, and has operated since 1999.
  • Net worth was Rs 1,044.75 crore on 30 September 2024.

Risks

  • The pre-issue P/E was 126.42 at the upper band of Rs 549, based on EPS of Rs 4.34.
  • Margins are thin, and the source puts the PAT margin at 5.65%.
  • Total borrowing was Rs 764.49 crore on 30 September 2024.
  • CRDMO income depends on client pipelines and global biotech funding, and Rs 2,092.62 crore of the issue was offer for sale.
  • Promoters held only 41.82% before the issue and 35.24% after it.

Promoters and shareholding

Kanumuri Ranga Raju, Krishnam Raju Kanumuri, Kanumuri Mytrey, Sai Quest Syn Pvt.Ltd, Sunflower Partners, Lily Partners, Marigold Partners and Tulip Partners

Promoter holding, pre-issue
41.82%
Promoter holding, post-issue
35.24%

Registrar, lead managers and documents

Sai Life Sciences IPO: common questions

1.When does the Sai Life Sciences IPO open and close?

The Sai Life Sciences IPO opens on 11 Dec 2024 and closes on 13 Dec 2024.

2.What is the price band of the Sai Life Sciences IPO?

The price band is ₹522 – ₹549 per share, with a lot size of 27 shares and a minimum investment of ₹14,823.

3.What is the size of the Sai Life Sciences IPO?

The issue size is ₹3,042.62 Cr (Fresh capital cum OFS).

4.What is the GMP of the Sai Life Sciences IPO?

The last reported grey market premium is ₹70 per share as of 17 Dec 2024, 12:00 PM IST. GMP is unofficial and changes frequently.

5.When is the Sai Life Sciences IPO allotment?

The basis of allotment is expected on 16 Dec 2024. Allotment status can be checked with the registrar, KFin Technologies Limited.

6.When will the Sai Life Sciences IPO list?

The shares listed on 18 Dec 2024 on BSE, NSE.

7.Who is the lead manager of the Sai Life Sciences IPO?

The book running lead managers are Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, IIFL Capital Services Limited, Morgan Stanley India Co. Pvt. Ltd, and the registrar is KFin Technologies Limited.

8.What will the money raised in the Sai Life Sciences IPO be used for?

As stated in the offer document, the proceeds are for: Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company; General corporate purposes.

9.How can my company launch an IPO like Sai Life Sciences?

Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393